8-K: Strive Subsidiary Secures $20M Loan for DOJ Settlement

Strive's subsidiary, Semler Scientific, borrowed $20.0 million collateralized by Bitcoin to fund a U.S. Department of Justice settlement.

Summary

• Strive, Inc.'s merger partner, Semler Scientific, Inc., secured a $20.0 million cash loan from Coinbase Credit Inc. on September 25, 2025.
• The loan proceeds, combined with cash from operations, are intended to fully pay Semler Scientific's previously disclosed settlement with the U.S. Department of Justice.
• The loan is collateralized by Semler Scientific's Bitcoin holdings and carries a 10% interest rate.
• An initial margin percentage of 156.25% applies, meaning Semler Scientific could be required to transfer additional Bitcoin or eligible collateral if the value falls below minimum margin requirements.
• The loan matures on March 26, 2026, and includes an early termination fee equal to the full amount of all remaining interest through the term if paid prior to maturity.

Sentiment

Score: 4

Explanation: While resolving a legal issue is a positive step, incurring a $20.0 million debt at a 10% interest rate, collateralized by volatile Bitcoin, and subject to an early termination fee, introduces significant financial costs and risks. The underlying reason for the loan (DOJ settlement) is also a negative indicator.

Positives

• Secured funding to resolve a previously disclosed legal settlement with the U.S. Department of Justice, removing a significant liability.
• Utilizes existing Bitcoin holdings as collateral, potentially avoiding immediate equity dilution for this specific financing.

Negatives

• Incurred a $20.0 million debt at a 10% interest rate, which is a notable financial cost.
• The loan is collateralized by Bitcoin, exposing the company to margin call risks if the value of Bitcoin declines.
• An early termination fee equal to all remaining interest through the loan term limits financial flexibility.
• The necessity of securing a loan to pay a DOJ settlement indicates a past legal issue and associated financial burden.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed merger transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all, particularly due to changes in or problems arising from Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities due to the merger and financing activities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before the closing of the merger.

Future Outlook

The filing outlines the outlook and expectations of Strive and Semler Scientific regarding their proposed merger, anticipating strategic and financial benefits, including the expected impact on the combined company's future financial performance and the ability to successfully integrate the businesses. Semler Scientific intends to use the loan proceeds to fully pay its U.S. Department of Justice settlement.

Management Comments

• Semler Scientific intends to use the proceeds from the loan (along with cash from operations) to pay in full its previously disclosed settlement with the U.S. Department of Justice.

Industry Context

The use of Bitcoin as collateral for a corporate loan, particularly for a significant amount, reflects a growing trend among companies with substantial digital asset holdings to leverage these assets for corporate financing. This strategy, while innovative, introduces exposure to cryptocurrency market volatility and associated margin call risks. The merger itself is a strategic consolidation within the industry, aiming for combined operational and financial synergies.

Comparison to Industry Standards

• The 10% interest rate on a collateralized loan is relatively high, suggesting either a higher perceived risk by the lender or specific market conditions for digital asset-backed loans. For comparison, well-rated corporate debt typically carries lower interest rates, while uncollateralized or higher-risk debt can be higher.
• The use of Bitcoin as primary collateral is a non-traditional approach, though it has been adopted by a few public companies, notably MicroStrategy, which has also used its Bitcoin holdings to secure debt. This indicates a nascent but developing market for digital asset-backed corporate financing.
• The 156.25% initial margin percentage is a standard risk management practice for volatile assets like Bitcoin, providing a substantial buffer against price fluctuations before triggering margin calls, similar to practices in other commodity or derivatives markets.

Legal Proceedings

• Semler Scientific intends to use the loan proceeds to pay in full its previously disclosed settlement with the U.S. Department of Justice.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is listed as a risk factor for the proposed merger.

Stakeholder Impact

• Shareholders: Potential for dilution from Strive's issuance of additional shares for the merger; impact on share price due to new debt, interest costs, and Bitcoin collateral risks; resolution of the DOJ settlement removes a significant liability.
• Creditors: Coinbase Credit Inc. becomes a significant creditor with a first priority security interest in Semler Scientific's Bitcoin.
• Management: Diversion of attention to merger integration and managing the new debt obligations and associated collateral risks.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed merger.
• The Registration Statement will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Semler Scientific will use the loan proceeds, along with cash from operations, to pay its previously disclosed settlement with the U.S. Department of Justice.

Key Dates

Recommendation

While the resolution of a U.S. Department of Justice settlement is a positive step, the associated 10% interest rate on the $20 million loan and the use of volatile Bitcoin as collateral introduce new financial risks and costs. The ongoing merger process also carries inherent uncertainties and potential for dilution. Investors should hold to monitor the merger's progress, the company's ability to manage the debt, and the stability of Bitcoin collateral and its impact on the company's financial health.

Keywords

Strive, Semler Scientific, Merger, Loan, Bitcoin, Coinbase, DOJ Settlement, 8-K, Digital Assets, Corporate Debt, Collateralized Loan